EGFR and breast carcinoma: As seen in Figure 6A,C, lysosomal inhibitor Baf-A1 significantly recovered the degradation of ErbB proteins by HSP90 inhibitor 17AAG, while NH4Cl and CQ failed to recover the degradation in parental HER2-positive breast cancer cell lines.